Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : dsco Discovery Laboratories -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (49)	10/30/2003 9:15:39 PM
From: Cacaito	Read Replies (1) \| Respond to of 318

Td, I sold my position and waiting for re-entrance, and it seems that my re-entrance price ($5 to $6) will have to give up. There is a nice article post in the other thread, about a Survanta ARDS trial in children, decent trial and very good results, from Turkey. As turkey as it sounds, there are plenty of good clinical trials done in Turkey. The company has a boost in New Orleans this weekend for a major Pediatrics meeting, I do not know if they are presenting.